About NSG BioLabs
NSG BioLabs is a Healthcare company based in Singapore (Singapore) founded in 2019 by Daphne Teo. Level 2 biosafety co-working labs and office spaces are provided. NSG BioLabs has raised $14.5 million across 1 funding round from investors including ClavystBio and Celadon Partners. Its chief executive, as recorded, is Daphne Teo. Its focus areas include HealthTech, Life Sciences Tech, Coworking Labs and Life Sciences.
Company details
NSG BioLabs was established in 2019 in Singapore as a provider of shared laboratory and office facilities under level 2 biosafety standards. Operations focus on supporting molecular, cellular, and microbiological research through equipped workspaces. HEPA-filtered HVAC systems are utilized for air quality control, with dedicated areas allocated for tissue culture and microbial experiments. Services cater to biotechnology and life sciences sectors in the region.
- Headquarters Singapore, Singapore
- Founders Daphne Teo
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nsgbio.com
- Social LinkedIn Instagram
- Total Equity Funding$14.5M (USD)
in 1 rounds
- Latest Funding Round$14.5M (USD), Series B
May 2024
- InvestorsClavystBio
& 1 more
Funding Insights of NSG BioLabs
NSG BioLabs has successfully raised a total of $14.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.5M
- Total Rounds 1
- Last Round Series B — $14.5M
- First Round $14.5M
(May 2024)
- Investors Count 2
All 1 funding rounds of NSG BioLabs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $14.5M | Series B | – | Clavystbio, Celadon Partners | – |
2 investors in total: 2 institutional.
Investors in NSG BioLabs
NSG BioLabs has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include ClavystBio and Celadon Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| celadonpartners.com | ||||
ClavystBio is engaged in life sciences investment and venture building. | clavystbio.com | Singapore, Singapore |
Investor details for NSG BioLabs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NSG BioLabs
1 people are tracked at NSG BioLabs (1 in leadership).
| Name | Role | Group |
|---|---|---|
Daphne Teo | Founder & CEO | Leadership |
Complete people profiles for NSG BioLabs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NSG BioLabs
2 dated milestones of NSG BioLabs across 5 years, from founding to its latest funding, stage changes and deals.
- Founded NSG BioLabs is founded.
- Funding First funding round of $14.5M.
Web traffic of NSG BioLabs
The website of NSG BioLabs (nsgbio.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 16.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nsg Biolabs
Complete news archive for NSG BioLabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NSG BioLabs
NSG BioLabs was founded in 2019 and raised its 1st funding round 5 years after it was founded.
NSG BioLabs is headquartered in Singapore, Singapore.
Daphne Teo is the CEO of NSG BioLabs, as recorded in our data. They have also founded this company.
NSG BioLabs is a funded company, having raised a total of $14.5M across 1 funding round to date. The company's 1st funding round was a Series B of $14.5M, raised on May 2024.
NSG BioLabs was established in 2019 in Singapore as a provider of shared laboratory and office facilities under level 2 biosafety standards. Operations focus on supporting molecular, cellular, and microbiological research through equipped workspaces. HEPA-filtered HVAC systems are utilized for air quality control, with dedicated areas allocated for tissue culture and microbial experiments. Services cater to biotechnology and life sciences sectors in the region.
NSG BioLabs has 2 investors. Key investors include ClavystBio, and Celadon Partners.